Persistent URL of this record https://hdl.handle.net/1887/111642
In Collections
This item can be found in the following collections:
INCREMENTAL BENEFIT OF OPEN-LABEL CERTOLIZUMAB PEGOL plus MTX IN RHEUMATOID ARTHRITIS (RA) PATIENTS FOLLOWING DOUBLE-BLIND PLACEBO plus MTX TREATMENT OUT TO 2 YEARS
- All authors
- Combe, B.; Schwartzman, S.; Massarotti, E.; Keystone, E.C.; Luijtens, K.; Heijde, D. van der
- Date
- 2010-04-30
- Title of host publication
- Rheumatology
- Volume
- 49
- Pages
- I96I97